# Local Injection Methylene Blue Combined With Radiation in HNSCC Patients

> **NCT07435415** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **China Medical University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Head and Neck Cancer
- Local Recurrent Tumor

## Interventions

- **DRUG:** Methylene Blue (50 mg/10ml)

## Key facts

- **NCT ID:** NCT07435415
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07435415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07435415, "Local Injection Methylene Blue Combined With Radiation in HNSCC Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07435415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*